Pipeline

We are tirelessly developing transformative treatments for aging diseases. But beyond treating symptoms, our approach targets the root causes. By leveraging cutting-edge biotechnologies, we delve deep into biochemical and cellular mechanisms and genetic pathways.
 
Exploring untapped potential in biotechnology, we are continually refining our strategies and methodologies. Our dynamic pipeline promises not just advancements, but potential game-changers for patients globally.

In the face of aging diseases, we stand as a testament to human perseverance. Our mission transcends science, reaching into the core of humanity. With an innovative pipeline and a passion for transformation, we are not just changing the narrative of aging – but reshaping its future.

Neurology

Focusing on Alzheimer's disease, Parkinson's disease
and Long COVID

Our neurology strategy is centered at what we understand to be the nexus of biochemistry, cellular energetics, and neuroprotection, enabling us to explore the potential of our pipeline molecules to decrease inflammation, enhance glucose utilization, protect neurons, and facilitate energy transfer within the central nervous system, ultimately leading to improvements in memory and movement, and a healthier brain. Our lead Neuroscience molecule (NE3107) is currently being investigated in human clinical studies to assess its hypothesized impact on both Alzheimer’s and Parkinson’s.

Hepatology

Focusing on Liver Cirrhosis and Refractory Ascites

In our pursuit of a breakthrough, we are taking a fresh and comprehensive approach to understanding the biology and physiology underlying ascites. Our strategy involves synergizing existing technologies with innovative applications to craft a potential remedy for this challenging condition. This endeavor represents a critical milestone in our commitment to addressing the pressing medical needs of patients affected by ascites, offering them new hope for improved quality of life and better outcomes.